Page last updated: 2024-08-24

capecitabine and Cryptogenic Fibrosing Alveolitis

capecitabine has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brewer, JD; Markovic, SN; Parikh, SA	1

Other Studies

1 other study(ies) available for capecitabine and Cryptogenic Fibrosing Alveolitis

Article	Year
Oral capecitabine to prevent recurrent cutaneous squamous cell carcinoma in a lung transplant recipient. International journal of dermatology, 2015, Volume: 54, Issue:9 Topics: Administration, Oral; Adult; Capecitabine; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Living Donors; Lung Transplantation; Reoperation; Skin Neoplasms; Transplantation Immunology; Treatment Outcome	2015

Article

Year

Oral capecitabine to prevent recurrent cutaneous squamous cell carcinoma in a lung transplant recipient.

International journal of dermatology, 2015, Volume: 54, Issue:9

Topics: Administration, Oral; Adult; Capecitabine; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Graft Rejection; Humans; Idiopathic Pulmonary Fibrosis; Living Donors; Lung Transplantation; Reoperation; Skin Neoplasms; Transplantation Immunology; Treatment Outcome

2015